机译:急性脑卒中患者血浆纤溶酶原激活物抑制剂1型(PAI-1)基因4G / 5G多态性频率与血浆PAI-1酶活性之间的相关性研究
Banu KucukarabaciDepartment of Medical Biology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.Hasan Veysi GunesDepartment of Medical Biology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.Gazi OzdemirDepartment of Neurology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.Didem CosanDepartment of Medical Biology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.Demet OzbabalikDepartment of Neurology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.Miris DikmenDepartment of Pharmacology, Pharmacy Faculty, Anadolu University, Eskisehir, Turkey.Irfan DegirmenciDepartment of Medical Biology, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.;
机译:急性脑卒中患者血浆纤溶酶原激活物抑制剂1型(PAI-1)基因4G / 5G多态性频率与血浆PAI-1酶活性之间的相关性研究
机译:反应蛋白,纤溶酶原激活物抑制剂1型(PAI-1)水平,PAI-1启动子4G / 5G多态性和急性心肌梗死
机译:ECTIM研究中,纤溶酶原激活物抑制剂1(PAI-1)基因启动子中的4G / 5G遗传多态性与血浆PAI-1活性的差异有关,但与心肌梗塞的风险无关。练习曲练习曲
机译:血液原激活剂抑制剂-1基因中缺乏4g / 5g多态性的关联卒中
机译:魁北克家庭研究中PAI-1 4G / 5G多态性与血压的关联:与肥胖,身体活动和ACE I / D多态性的相互作用。
机译:4G / 5G纤溶酶原激活物抑制剂1(PAI-1)基因多态性和PAI-1血浆水平在严重脓毒症患者预后中的作用
机译:急性心肌梗死患者纤维蛋白溶解治疗后血浆纤溶酶原激活剂抑制剂浓度的增加与PAI-1基因的4g / 5g多态性相关